Bold plans for new colourful boathouses on Bristol's Floating Harbour

Young Bristol wants to make it easier to get equipment into and out of the water ...
pharmaphorum

Amgen eyes swift move to ph3 for cardiovascular drug olpasiran

Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...
pharmaphorum

After ph3 win, Roche eyes earlier use of Columvi in DLBCL

Roche’s CD20xCD3 bispecific antibody Columvi has improved survival when used as a second-line therapy for diffuse large B-cell lymphoma (DLBCL) in a phase 3 trial, setting up regulatory filings for ...
The Malaysian Reserve

Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...
San Diego Union-Tribune

San Diego Union-Tribune

⚽ Olympics at Snapdragon ️ Airports on ‘hot spots’ list ⚓ USS Nimitz 🍨 An’s Gelato at the Top Gun House ⭐ Broadway coming to S.D. Fewer people are riding the San Diego trolley. Officials blame the ...